GlassScriptPhysician profile
Diane Stoller
NPI 1134207160
$2,627.30
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,534 · 2022: $92.96.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,208.44 | 2019 | |
| Genentech USA, INC. | $148.84 | 2019 | |
| Hologic INC | $92.96 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $59.70 | 2019 | |
| Eisai INC. | $31.28 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $20.53 | 2019 | |
| Puma Biotechnology, INC. | $17.63 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $17.32 | 2019 | |
| Merck Sharp & Dohme LLC | $15.57 | 2019 | |
| Celgene Corporation | $15.03 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Diane Stoller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.